Disc Medicine (IRON) Stock Forecast & Price Target

$50.07

+2.02 (+4.20%)

(As of 09/27/2024 ET)

Disc Medicine - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 8 Analyst Ratings

Sell
0

Hold
1

Buy
7

Based on 8 Wall Street analysts who have issued ratings for Disc Medicine in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 1 has given a hold rating, and 7 have given a buy rating for IRON.

Consensus Price Target

$64.13
28.07% Upside

According to the 8 analysts' twelve-month price targets for Disc Medicine, the average price target is $64.13. The highest price target for IRON is $85.00, while the lowest price target for IRON is $40.00. The average price target represents a forecasted upside of 28.07% from the current price of $50.07.

Get the Latest News and Ratings for IRON and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Disc Medicine and its competitors.

IRON Analyst Ratings Over Time

Type	Current Forecast 9/30/23 to 9/29/24	1 Month Ago 8/31/23 to 8/30/24	3 Months Ago 7/2/23 to 7/1/24	1 Year Ago 9/30/22 to 9/30/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	9 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$64.13	$64.13	$62.57	$53.78
Forecasted Upside	28.07% Upside	26.18% Upside	34.65% Upside	14.47% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)

Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?

Click Here to learn how to get in now >>>

IRON Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

IRON Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Disc Medicine Stock vs. The Competition

Type	Disc Medicine	Medical Companies	S&P 500
Consensus Rating Score	2.88	2.78	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	28.07% Upside	818.78% Upside	6.16% Upside
News Sentiment Rating	Positive News See Recent IRON News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/20/2024	Cantor Fitzgerald 3 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$85.00 ➝ $85.00	+77.82%
9/16/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$70.00 ➝ $70.00	+46.47%
8/22/2024	Wells Fargo & Company 3 of 5 stars	T. Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$75.00	+52.10%
8/9/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$57.00 ➝ $57.00	+35.01%
6/17/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$50.00 ➝ $70.00	+51.29%
5/10/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$40.00 ➝ $43.00	+41.08%
Get the Latest News and Ratings for IRON and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Disc Medicine and its competitors with MarketBeat's FREE daily newsletter.
4/8/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$71.00 ➝ $73.00	+144.31%
4/2/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$75.00 ➝ $40.00	+24.53%
4/24/2023	Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Katkhuda Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/28/2023	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform	$36.00	+47.60%
2/28/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$36.00	+47.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:26 PM ET.

IRON Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Disc Medicine is $64.13, with a high forecast of $85.00 and a low forecast of $40.00.
: 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Disc Medicine in the last year. There is currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" IRON shares.
: According to analysts, Disc Medicine's stock has a predicted upside of 28.07% based on their 12-month stock forecasts.
: Disc Medicine has been rated by research analysts at Cantor Fitzgerald, HC Wainwright, Wedbush, and Wells Fargo & Company in the past 90 days.
: Analysts like Disc Medicine more than other "medical" companies. The consensus rating score for Disc Medicine is 2.88 while the average consensus rating score for "medical" companies is 2.78. Learn more on how IRON compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Protect Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

This page (NASDAQ:IRON) was last updated on 9/29/2024 by MarketBeat.com Staff

From Our Partners